Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00339
|
|||||
| Drug Name |
Calcium phosphate
|
|||||
| Synonyms |
Bonarka; Calcigenol simple; Calcium orthophosphate; Calcium phosphate; Calcium phosphate (3:2); Calcium phosphate (Ca3(PO4)2); Calcium phosphate tribasic; Calcium tertiary phosphate; Natural whitlockite; Phosphoric acid, calcium salt; Phosphoric acid, calcium salt (2:3); Synthos; TRICALCIUM PHOSPHATE; Tertiary calcium phosphate; Tribasic calcium phosphate; Tricalcium diphosphate; Tricalcium orthophosphate; beta-TCP; beta-Tricalcium phosphate
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Osteoporosis [ICD11: FB83.1] | Phase 2 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
Ca3O8P2
|
|||||
| Canonical SMILES |
[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[Ca+2].[Ca+2].[Ca+2]
|
|||||
| InChI |
InChI=1S/3Ca.2H3O4P/c;;;2*1-5(2,3)4/h;;;2*(H3,1,2,3,4)/q3*+2;;/p-6
|
|||||
| InChIKey |
QORWJWZARLRLPR-UHFFFAOYSA-H
|
|||||
| CAS Number |
CAS 7758-87-410103-46-5
|
|||||
| Pharmaceutical Properties | Molecular Weight | 310.18 | Topological Polar Surface Area | 173 | ||
| Heavy Atom Count | 13 | Rotatable Bond Count | 0 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 8 | |||
| PubChem CID | ||||||
| ChEBI ID |
ChEBI:9679
|
|||||
| DT(s) Transporting This Drug | NPT2A | Transporter Info | Sodium-dependent phosphate transport protein 2A | Substrate | [2] | |
| References | ||||||
| 1 | ClinicalTrials.gov (NCT00074711) Adding Phosphorus to Osteoporosis Drug Treatment | |||||
| 2 | Phosphate transporters and their function. Annu Rev Physiol. 2013;75:535-50. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.